What is FSD Pharma Inc. (HUGE) stock price today?

FSD Pharma Inc. (HUGE) is currently trading at $0.09, down 10.1% today.

What is HUGE P/E ratio?

FSD Pharma Inc.'s P/E ratio is -0.19. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is HUGE return on equity (ROE)?

FSD Pharma Inc.'s return on equity (ROE) is -84.81%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is FSD Pharma Inc.'s market cap?

FSD Pharma Inc. has a market capitalization of $66671.

NASDAQ · Drug Manufacturers - Specialty & Generic

FSD Pharma Inc. (HUGE) Stock

$0.09 -10.10% NASDAQ: HUGE Healthcare

FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries.

Valuation

Metric	Value
Price	$0.09
Market Cap	$66671
P/E Ratio	-0.19
P/B Ratio	0.27
P/S Ratio	0.00
EPS (TTM)	$-0.47
52-Week High	$109.19
52-Week Low	$0.09
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-84.81%
ROA	-106.24%
ROCE	-154.10%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.03
Current Ratio	2.44

Annual Financials (USD)

Metric	2019	2020	2021	2022	2023
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-31.0M	$-31.0M	$-34.0M	$-27.0M	$-20.0M
Net Profit	$-40.0M	$-33.0M	$-35.0M	$-23.0M	$-19.0M
EPS	$-5.68	$-2.72	$-1.01	$-0.60	$-0.47
Op Margin	-15536.3%	—	—	—	—

Balance Sheet (USD)

Metric	2019	2020	2021	2022	2023
Total Assets	$44.0M	$42.0M	$63.0M	$38.0M	$17.0M
Total Liabilities	$7.0M	$6.0M	$9.0M	$8.0M	$5.0M
Cash	$6.0M	$18.0M	$35.0M	$17.0M	$3.0M
Borrowings	$2.0M	$1.0M	$1.0M	$1.0M	$0

Latest News

Tenet Healthcare (THC) Reports Earnings Tomorrow: What To Expect StockStory · Jul 23, 2026 Low-Cost Developed Markets or Emerging-Market Tech Exposure? VEA vs. IEMG Motley Fool · Jul 23, 2026 GE Vernova’s AI power trade has one weak link TheStreet · Jul 23, 2026 Flagstar Financial Earnings: What To Look For From FLG StockStory · Jul 23, 2026 Eni and KazMunayGas Reach Key Milestone at Kazakhstan Hybrid Power Plant Oilprice.com · Jul 23, 2026

Cash Flow (USD)

Metric	2019	2020	2021	2022	2023
Operating Cash Flow	$-14.0M	$-19.0M	$-21.0M	$-28.0M	$-11.0M
Investing Cash Flow	$-1.0M	$7.0M	$0	$12.0M	$0
Financing Cash Flow	$4.0M	$0	$0	$-2.0M	$-3.0M
Net Cash Flow	$-10.0M	$12.0M	$18.0M	$-18.0M	$-14.0M
Free Cash Flow	$-15.0M	$-19.0M	$-21.0M	$-29.0M	$-11.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.15
FCF Yield	-16537.66%
Quick Ratio	2.44
Interest Coverage	-65451.89
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACORAcorda Therapeutics, Inc.	$0.66	-24.02%	0.00	$821028	0.00%
BFRIBiofrontera Inc.	$0.89	-3.56%	-1.69	$11.42M	0.00%
BHHKFCraftport Cannabis Corp.	$0.00	—	0.00	$884	0.00%
CNNACann American Corp.	$0.01	+8.33%	0.53	$4.80M	0.00%
CVGRFCity View Green Holdings Inc.	$0.03	+0.00%	-2.23	$1.53M	0.00%

About FSD Pharma Inc.

FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries. The firm's leading drug candidate, FSD-201, is currently undergoing Phase II clinical trials for the treatment of COVID-19 disease. Additionally, FSD Pharma is actively developing Lucid-PSYCH, a psychoactive molecule identified for its potential in addressing neuropsychiatric conditions such as depressive disorder. They are also advancing Lucid-MS, a proprietary new chemical entity which, in preclinical models, has demonstrated the capacity to prevent and reverse myelin degradation—the fundamental mechanism behind multiple sclerosis. Established in 1998, FSD Pharma Inc. is headquartered in Toronto, Canada.

FSD Pharma Inc. is headquartered in CA.

FSD Pharma Inc. (HUGE) stock trades at $0.09 with a market capitalization of $66671. The stock is valued at a price-to-earnings (P/E) ratio of -0.19, price-to-book of 0.27, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.09 and $109.19, and currently trades 99.9% below its 52-week high.

On profitability, FSD Pharma Inc. generates a return on equity (ROE) of -84.81%, return on capital employed of -154.10%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.fsdpharma.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1166.51 -1.36% JNJ Johnson & Johnson $248.61 -5.73% ABBV AbbVie Inc. $274.31 -2.42% MRK Merck & Company, Inc. Common Stock (new) $141.98 -2.39% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.76 -0.20% NVS Novartis AG $142.41 -0.99% TMO Thermo Fisher Scientific Inc $663.04 +0.12% AZN AstraZeneca PLC $155.82 -1.59% AMGN Amgen Inc. $412.84 -1.13% GILD Gilead Sciences, Inc. $147.92 -1.67% ABT Abbott Laboratories $102.67 +0.83% NVO Novo Nordisk A/S $38.06 -1.35%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides